These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16574677)
21. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF; Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398 [TBL] [Abstract][Full Text] [Related]
22. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):252-8. PubMed ID: 14742990 [TBL] [Abstract][Full Text] [Related]
23. [Evidences in immunosuppression in the maintenance of renal transplantation]. Hernández D; González-Posada JM Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502 [No Abstract] [Full Text] [Related]
24. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
25. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients. Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943 [TBL] [Abstract][Full Text] [Related]
26. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516 [TBL] [Abstract][Full Text] [Related]
27. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients. Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665 [TBL] [Abstract][Full Text] [Related]
28. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153 [TBL] [Abstract][Full Text] [Related]
31. The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine. Lim WH; Russ GR; Wong G; Pilmore H; Kanellis J; Chadban SJ Kidney Int; 2017 Apr; 91(4):954-963. PubMed ID: 28109543 [TBL] [Abstract][Full Text] [Related]
32. Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs. Flechner SM; Goldfarb D; Solez K; Modlin CS; Mastroianni B; Savas K; Babineau D; Kurian S; Salomon D; Novick AC; Cook DJ Transplantation; 2007 Apr; 83(7):883-92. PubMed ID: 17460558 [TBL] [Abstract][Full Text] [Related]
33. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
35. [Change in regulations for dispensing immunosuppressants to patients who have undergone a kidney transplant]. Gulín Dávila J; López Rodríguez L Nefrologia; 2010; 30(3):370-1. PubMed ID: 20514108 [No Abstract] [Full Text] [Related]